Examkin

Tüm alıştırma soruları

858 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 761Soru →

A primary care physician is evaluating several ambulatory patients who have not been taking their prescribed therapies. To improve clinical outcomes, the physician must tailor their approach to the specific underlying barrier. Select the most appropriate initial counseling strategy or intervention for each of the following patient scenarios.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

I stopped taking the amlodipine because my ankles became so swollen I could not put my shoes on.
I only take the lisinopril when I get a bad headache, because that is how I know my blood pressure is high.
When I went to pick up the apixaban, the pharmacist said the copay was $200, so I just left it there.
I have eight different pill bottles now, and I honestly cannot keep track of what I am supposed to take when.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Each patient statement must be matched to the counseling strategy that directly addresses their specific root cause of non-adherence: adverse effects, health beliefs, financial constraints, and regimen complexity, respectively.
Matching the correct counseling strategy to the specific barrier ensures that the intervention is patient-centered and effective. Validating side effects builds trust; correcting health beliefs addresses knowledge gaps; providing financial resources overcomes systemic barriers; and simplifying regimens reduces cognitive overload.

Adım Adım Çözüm

1
Analyze each patient's statement to determine the underlying barrier to medication adherence.
Identified barriers: adverse medication effect, misunderstanding of disease process, cost/financial constraint, and regimen complexity.
Targeted counseling is only effective when it addresses the specific root cause of the patient's non-adherence.
2
Select the physician intervention that directly mitigates the identified barrier.
Matched each barrier to its corresponding practical clinical or educational solution.
Applying mismatched strategies will fail to improve patient adherence or clinical outcomes.

Anahtar Kavram

Tailoring physician counseling and clinical interventions to the specific barrier causing medication non-adherence.
Soru 762Soru →

Match each clinical scenario involving an incapacitated patient with the ethical standard, legal doctrine, or framework that most accurately justifies the decision-making process.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A designated health care agent authorizes a 'Do Not Resuscitate' order for a comatose patient, citing a specific past conversation about the patient's end-of-life values.
A state-appointed guardian consents to a routine appendectomy for an adult patient who has had severe, lifelong cognitive impairment and never possessed decision-making capacity.
A trauma surgery team immediately initiates a massive transfusion protocol on an unidentified, hypotensive pedestrian struck by a commercial vehicle.
An attending physician seeks consent for a percutaneous feeding tube from an incapacitated patient's adult daughter only after confirming the patient's spouse is deceased.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings align the patient scenarios with their corresponding legal or ethical frameworks: the agent acting on prior conversations utilizes the substituted judgment standard; the guardian for a lifelong incapacitated patient uses the best interest standard; the trauma team acts under the emergency implied consent doctrine; and the physician contacting the daughter after verifying the spouse's death follows the statutory surrogate hierarchy.
Each clinical vignette clearly demonstrates one of the fundamental pillars of medical decision-making for incapacitated adults: substituted judgment (relying on the patient's known wishes), best interest (maximizing objective medical benefit when wishes are unknown/unformed), emergency exception (presuming consent for life-saving care), and statutory hierarchy (following state law to identify a default surrogate).

Adım Adım Çözüm

1
Analyze the patient's prior capacity and the surrogate's basis for decision-making in the first two scenarios.
Identify that relying on past conversations involves stepping into the patient's shoes, whereas making decisions for someone who never had capacity requires weighing objective benefits.
Differentiating between substituted judgment and the best interest standard depends entirely on whether the patient previously had capacity and expressed relevant values.
2
Evaluate the clinical acuity and availability of surrogates in the trauma scenario.
Determine that the immediate threat to life without an available surrogate triggers a specific legal exception to informed consent.
Medical emergencies require immediate action, overriding the standard requirement to obtain consent prior to intervention.
3
Assess the rationale behind the physician's sequence of contacting family members in the final scenario.
Recognize that the physician is following a legally mandated order of operations to identify the appropriate decision-maker.
State laws provide a structured order of priority to prevent disputes when an incapacitated patient lacks a designated proxy.

Anahtar Kavram

Surrogate decision-making frameworks follow a structured approach based on the patient's prior capacity, the presence of advance directives, and the clinical urgency of the situation.
Soru 763Soru →

A multidisciplinary discharge planning committee is reviewing the profiles of four hospitalized individuals who are preparing for transition out of the acute care ward. Match each patient profile with the most appropriate post-acute care setting that best aligns with clinical guidelines, medical complexity, and rehabilitation tolerance.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Medically complex patient requiring prolonged mechanical ventilator weaning and aggressive daily debridement of a stage IV sacral decubitus ulcer.
Post-stroke patient with dense hemiparesis who is highly motivated and capable of participating in 3 hours of rigorous daily multidisciplinary therapy.
Frail patient status-post hip arthroplasty needing daily physical therapy, but who fatigues rapidly after 45 minutes of physical exertion.
Medically stable patient completing a six-week course of intravenous daptomycin for osteomyelitis, fully independent with mobility and daily activities.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct mapping pairs the ventilator weaning patient with LTACH, the patient tolerating 3 hours of therapy with IRF, the frail post-arthroplasty patient with SNF, and the stable IV antibiotic patient with Home Health.
Each setting has strict criteria: LTACHs manage high medical acuity requiring prolonged hospitalization, IRFs require a minimum of 3 hours of daily therapy tolerance, SNFs accommodate lower therapy tolerance with skilled nursing needs, and Home Health manages specific medical interventions in stable, independent patients living in the community.

Adım Adım Çözüm

1
Assess the patient requiring prolonged ventilator weaning and extensive wound care.
Matches with Long-Term Acute Care Hospital (LTACH).
These patients have high medical acuity requiring extended hospitalization (typically >25 days) but do not require acute ICU interventions.
2
Evaluate the post-stroke patient's rehabilitation capacity.
Matches with Inpatient Rehabilitation Facility (IRF).
The ability to tolerate 3 hours of daily multidisciplinary therapy is the core requirement for IRF admission.
3
Analyze the frail post-arthroplasty patient's endurance.
Matches with Skilled Nursing Facility (SNF).
Needing daily physical therapy but only tolerating 45 minutes disqualifies the patient from an IRF, making a SNF the appropriate step-down level of care.
4
Determine the needs of the patient on IV daptomycin.
Matches with Home Health Agency (HHA) services.
Being medically stable and independent means inpatient post-acute care is unnecessary; home health can safely manage vascular access and intermittent infusions.

Anahtar Kavram

Clinical acuity, rehabilitation tolerance, and specific skilled nursing needs dictate the appropriate post-acute care setting according to Medicare-defined admission criteria.
Soru 764Soru →

For the following adult patients receiving end-of-life care, identify the most appropriate targeted pharmacologic therapy to manage their acute distressing symptoms.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

An 82-year-old gentleman with severe idiopathic pulmonary fibrosis on maximal inhaler therapy and continuous supplemental oxygen who continues to experience agonizing breathlessness at rest.
A 69-year-old woman in the active phase of dying from glioblastoma who is unconscious and producing loud, gurgling respiratory noises that are deeply distressing to her spouse.
A 58-year-old man with metastatic cholangiocarcinoma and newly oliguric acute kidney injury who develops diffuse myoclonus and severe allodynia while receiving high-dose intravenous hydromorphone.
A 75-year-old man with end-stage liver disease receiving home hospice care who begins striking at caregivers and screaming about intruders, completely refractory to environmental redirection.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The clinical scenarios are correctly paired with their specific symptom-directed therapies: the patient with dyspnea requires a systemic opioid, the patient with terminal secretions requires a muscarinic antagonist, the patient with opioid neurotoxicity and acute kidney injury requires opioid rotation, and the patient with agitated terminal delirium requires an antipsychotic.
Each clinical scenario presents a classic end-of-life symptom requiring a targeted pharmacologic intervention. Dyspnea is best managed with opioids to reduce the perception of breathlessness. Terminal secretions respond to anticholinergics that decrease fluid production. Opioid neurotoxicity in renal failure necessitates rotation to an opioid metabolized safely, like fentanyl. Severe agitated delirium is treated with antipsychotics when non-pharmacological interventions fail.

Adım Adım Çözüm

1
Evaluate the 82-year-old patient with refractory dyspnea.
Recognize that opioids are the gold standard for treating dyspnea at the end of life.
Opioids decrease the central respiratory drive and alleviate the sensation of air hunger.
2
Assess the 69-year-old patient with loud, gurgling respiratory noises.
Identify this as terminal secretions ('death rattle').
These secretions require anticholinergic drying agents, as suctioning is often ineffective and distressing.
3
Analyze the 58-year-old patient with myoclonus, allodynia, and acute kidney injury on hydromorphone.
Diagnose opioid-induced neurotoxicity due to metabolite accumulation.
Renal failure prevents the clearance of neurotoxic metabolites; the patient must be rotated to a renally safe opioid like fentanyl.
4
Evaluate the 75-year-old patient with hyperactive, aggressive behavior.
Diagnose terminal agitated delirium.
When non-pharmacologic measures fail, antipsychotics are required to manage severe agitation and ensure safety.

Anahtar Kavram

Pharmacologic management of terminal symptoms (dyspnea, secretions, delirium, opioid neurotoxicity) in end-of-life care
Soru 765Soru →

A prospective cohort study evaluates the impact of a novel genetic marker on the development of severe coronary artery disease (CAD) over 1010 years. The incidence of CAD is 10%10\% in the exposed group (marker positive) and 2%2\% in the unexposed group (marker negative). The overall incidence of CAD in the entire study population is 3.6%3.6\%. Match each calculated epidemiological value below to its corresponding measure of association or impact.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

5.05.0
8.0%8.0\%
80.0%80.0\%
1.6%1.6\%
12.512.5

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are: 5.0 matches Relative Risk; 8.0% matches Attributable Risk; 80.0% matches Attributable Risk Percent; 1.6% matches Population Attributable Risk; and 12.5 matches Number Needed to Harm.
Each value is mathematically derived from the fundamental incidence rates: Relative Risk is the ratio of exposed to unexposed incidence (5.05.0); Attributable Risk is the absolute difference (8.0%8.0\%); Attributable Risk Percent is the proportion of risk in the exposed due to the exposure (80.0%80.0\%); Population Attributable Risk is the difference between total population risk and unexposed risk (1.6%1.6\%); and Number Needed to Harm is the inverse of the Attributable Risk in decimal form (12.512.5).

Adım Adım Çözüm

1
Extract the relevant incidence rates provided in the study scenario.
Incidence in exposed (IeI_e) = 10%10\%; Incidence in unexposed (IuI_u) = 2%2\%; Total population incidence (ItI_t) = 3.6%3.6\%.
Identifying these baseline parameters is required before applying the formulas for measures of association and impact.
2
Calculate the Relative Risk (RR) and the absolute Attributable Risk (AR).
RR=IeIu=10%2%=5.0RR = \frac{I_e}{I_u} = \frac{10\%}{2\%} = 5.0. AR=Ie−Iu=10%−2%=8.0%AR = I_e - I_u = 10\% - 2\% = 8.0\%.
RR quantifies how many times more likely the outcome is in the exposed, while AR provides the absolute excess risk.
3
Calculate the Attributable Risk Percent (ARP) for the exposed group.
ARP=Ie−IuIe=10%−2%10%=80.0%ARP = \frac{I_e - I_u}{I_e} = \frac{10\% - 2\%}{10\%} = 80.0\%.
ARP determines the fraction of the disease in the exposed group that can be specifically attributed to the genetic marker exposure.
4
Calculate the Population Attributable Risk (PAR).
PAR=It−Iu=3.6%−2.0%=1.6%PAR = I_t - I_u = 3.6\% - 2.0\% = 1.6\%.
PAR evaluates the excess disease incidence in the entire study population that is attributable to the risk factor.
5
Calculate the Number Needed to Harm (NNH).
NNH=1AR=10.08=12.5NNH = \frac{1}{AR} = \frac{1}{0.08} = 12.5.
NNH translates the absolute risk increase into a clinically intuitive metric of how many patients need to be exposed to observe one excess harmful event.

Anahtar Kavram

Measures of Association and Impact calculations
Soru 766Soru →

Determine the most appropriate validated risk stratification tool used to guide the immediate care setting disposition (e.g., safe outpatient discharge versus hospital admission) for each clinical scenario. Match each patient presentation to its corresponding disposition tool.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 68-year-old patient evaluated in the emergency department for fever, productive cough, and a new lobar infiltrate on chest radiograph.
A 60-year-old patient evaluated in the emergency department for a single episode of melena, blood urea nitrogen of 28 mg/dL, and stable vital signs.
A 45-year-old patient evaluated in the emergency department for sudden-onset pleuritic chest pain, normal vital signs, and a positive computed tomography pulmonary angiogram.
A 50-year-old patient evaluated in the emergency department for acute, non-radiating chest discomfort, a normal electrocardiogram, and negative initial troponin.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Community-Acquired Pneumonia matches CURB-65; Upper GI Bleeding matches Glasgow-Blatchford Score; Pulmonary Embolism matches PESI; Undifferentiated Chest Pain matches HEART Score.
Each clinical scenario corresponds to a specific acute condition where the immediate care setting disposition (outpatient vs. inpatient vs. ICU) is guided by a validated risk score. The CURB-65 score objectively evaluates community-acquired pneumonia. The Glasgow-Blatchford Score (GBS) evaluates the need for admission in upper gastrointestinal bleeding. The Pulmonary Embolism Severity Index (PESI) determines if outpatient management is safe for acute pulmonary embolism. The HEART score assesses undifferentiated chest pain to safely rule out acute coronary syndrome and avoid unnecessary hospital admissions.

Adım Adım Çözüm

1
Identify the underlying primary acute clinical condition for each patient vignette.
The scenarios describe community-acquired pneumonia, upper gastrointestinal bleeding, acute pulmonary embolism, and undifferentiated chest pain.
Disposition pathways and triage decisions are protocolized based on the specific acute disease process.
2
Determine the objective, disease-specific risk stratification tool intended to evaluate severity for each condition.
Pneumonia uses CURB-65 (or PSI); Upper GI bleed uses Glasgow-Blatchford; PE uses PESI; Chest pain uses HEART.
Safe care setting transitions require moving beyond clinical gestalt to objective mortality and complication risk prediction.
3
Map the specific scoring systems to their respective patient presentations.
Match each tool to its clinical scenario based on its role in guiding the immediate transition from the emergency department to either outpatient care or hospital admission.
This establishes the appropriate disposition pathway directly addressing the patient's immediate triage needs.

Anahtar Kavram

Validated risk stratification tools objectively guide disposition and care setting transitions by predicting short-term adverse outcomes, thereby identifying which patients are safe for outpatient management and which require hospital admission.
Soru 767Soru →

A primary care physician is reviewing the electronic health records of four established patients who are scheduled for annual health maintenance visits this morning. Match each patient's specific clinical presentation to the single most appropriate, guideline-concordant screening intervention that should be ordered or performed today.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 42-year-old female with average disease risk. Her most recent cervical cytology with HPV co-testing was performed at age 40 and was negative. She has never undergone breast imaging.
A 67-year-old male with a 35-pack-year smoking history who successfully quit smoking 10 years ago. He underwent a normal screening colonoscopy at age 62 and has no other major medical conditions.
A 23-year-old female who is asymptomatic and reports being sexually active with a new partner. Her last cervical cytology was performed at age 21 and was normal.
A 66-year-old female with documented adequate prior negative cervical cancer screenings. She had a normal screening mammogram at age 65 and a normal colonoscopy at age 60. She has never undergone bone density testing.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 42-year-old female matches with initiating biennial screening mammography. The 67-year-old male former smoker matches with ordering annual low-dose chest CT and a one-time abdominal aortic ultrasound. The 23-year-old sexually active female matches with chlamydia and gonorrhea screening. The 66-year-old female matches with ordering a DEXA scan.
Each patient represents a classic demographic for specific USPSTF Grade A or B recommendations. The 42-year-old needs breast cancer screening (starts at age 40). The 67-year-old male smoker needs lung and AAA screening (based on age and smoking history). The 23-year-old needs STI screening (indicated for sexually active women <25). The 66-year-old female needs osteoporosis screening (starts at age 65 for women).

Adım Adım Çözüm

1
Evaluate the 42-year-old female for age-appropriate screenings.
She is due for breast cancer screening.
Current USPSTF guidelines recommend starting biennial screening mammography at age 40 for average-risk women. Her cervical screening is up to date.
2
Evaluate the 67-year-old male former smoker for age and exposure-appropriate screenings.
He is due for both lung cancer and abdominal aortic aneurysm (AAA) screening.
He has a >20 pack-year history and quit <15 years ago, meeting LDCT criteria. He is a male aged 65-75 with a smoking history, meeting AAA ultrasound criteria.
3
Evaluate the 23-year-old sexually active female.
She is due for STI screening.
All sexually active women younger than 25 years require annual screening for chlamydia and gonorrhea. She is not yet due for her next Pap smear.
4
Evaluate the 66-year-old female with up-to-date cancer screenings.
She is due for osteoporosis screening.
Routine screening for osteoporosis with a DEXA scan is recommended for all women aged 65 years and older.

Anahtar Kavram

Age, biological sex, and risk factor-based application of USPSTF preventive screening guidelines.
Soru 768Soru →

Match each clinical scenario or calculation description to the appropriate measure of association or impact.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A study enrolls healthy volunteers and categorizes them by daily sodium intake over ten years, ultimately dividing the incidence of hypertension in the high-sodium group by the incidence in the low-sodium group.
Investigators identify patients with and without a specific foodborne illness, then mathematically compare the frequency of suspected restaurant exposure between the two groups.
A clinical trial evaluates a novel statin versus placebo, with researchers calculating the reciprocal of the absolute reduction in myocardial infarction incidence.
A surveillance analysis compares a new antiarrhythmic to a standard beta-blocker by subtracting the adverse event rate of the standard therapy from that of the new drug.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align cohort incidence ratios with Relative Risk, case-control exposure comparisons with Odds Ratio, the reciprocal of ARR with Number Needed to Treat, and adverse event rate differences with Absolute Risk Increase.
Each study design and mathematical approach inherently aligns with a specific biostatistical measure. Cohort studies utilizing true incidence ratios calculate Relative Risk. Case-control studies comparing exposure frequencies must calculate Odds Ratios. Taking the reciprocal of absolute reduction yields the Number Needed to Treat. Finally, the absolute mathematical difference in harm rates represents the Absolute Risk Increase.

Adım Adım Çözüm

1
Identify the study design and mathematical operation described in the first scenario.
The scenario describes dividing the incidence in an exposed group by an unexposed group in a cohort study, which mathematically defines Relative Risk.
Incidence ratios are the defining characteristic of relative risk calculations in observational cohort studies.
2
Analyze the study design based on disease status in the second scenario.
Starting with diseased and non-diseased individuals and comparing past exposures characterizes a case-control study, which utilizes the Odds Ratio.
Case-control studies cannot establish true incidence; therefore, they rely on the odds of exposure to estimate the association.
3
Determine the metric derived from the reciprocal of absolute risk reduction in the third scenario.
The formula 1/ARR1 / ARR specifically calculates the Number Needed to Treat (NNT).
NNT translates the absolute risk reduction into a clinically actionable number of patients needed to prevent one event.
4
Identify the metric representing the simple difference in adverse event rates in the fourth scenario.
Subtracting the standard event rate from a higher new event rate yields the Absolute Risk Increase (ARI).
ARI quantifies the absolute excess risk of harm attributable to a specific exposure or intervention.

Anahtar Kavram

Measures of Association and Impact
Soru 769Soru →

An investigative team is finalizing the protocol for a randomized controlled trial evaluating a novel pharmacologic intervention. During the planning phase, the biostatistics committee reviews several potential modifications to the study design to optimize its validity and efficiency. Match each proposed trial modification with its primary mathematical consequence.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Shifting the pre-study significance threshold (α\alpha) from 0.050.05 to 0.010.01 to meet stringent regulatory requirements.
Utilizing a surrogate clinical endpoint that yields a substantially larger expected standardized effect size.
Utilizing a rapid, less precise clinical measurement tool, which introduces greater random error into the primary outcome data.
Dichotomizing the primary continuous outcome variable (e.g., classifying patients strictly as 'responders' or 'non-responders').
Implementing a stratified randomization block design based on the strongest known prognostic demographic factor.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align each trial design modification with its direct mathematical impact on the study's error rates or statistical power components (numerator effect size, denominator variance, or data structure granularity).
Statistical power is mathematically dependent on the alpha level, effect size, sample variance, and data structure. Modifying these parameters directly alters the formal test statistic. Stratification isolates and removes known variance to increase power, while dichotomizing continuous variables destroys data granularity, causing a severe loss of efficiency.

Adım Adım Çözüm

1
Evaluate the impact of shifting the alpha threshold from 0.05 to 0.01.
Matches with: Decreases the probability of falsely rejecting the null hypothesis but simultaneously increases the Type II error rate.
Lowering alpha decreases the chance of a false positive (Type I error) but increases the chance of a false negative (Type II error), thereby lowering power.
2
Evaluate the impact of utilizing an endpoint with a larger effect size.
Matches with: Enhances statistical power by increasing the magnitude of the numerator in the formal test statistic calculation.
In test statistics (like the t-statistic), the difference between means sits in the numerator. A larger effect size increases this numerator, yielding a larger test statistic and higher power.
3
Evaluate the impact of introducing greater random error into the measurement.
Matches with: Reduces statistical power by inflating the denominator (standard error) of the formal test statistic.
Random error adds to the sample variance. Variance dictates the standard error, which is the denominator of the test statistic. A larger denominator yields a smaller test statistic, reducing power.
4
Evaluate the impact of dichotomizing a continuous outcome variable.
Matches with: Leads to a substantial loss of statistical power due to the discarding of continuous data granularity.
Reducing a rich continuous variable (e.g., exact blood pressure) to a binary outcome (e.g., hypertensive vs. normotensive) loses variance data, severely limiting the test's ability to detect true differences.
5
Evaluate the impact of implementing a stratified randomization block design.
Matches with: Increases statistical power by systematically reducing the unexplained residual variance in the outcome measure.
Stratification controls for known prognostic variables, removing their contribution from the 'noise' (residual variance). Less noise means a smaller standard error and therefore greater power.

Anahtar Kavram

Hypothesis Testing and Statistical Power
Soru 770Soru →

Match each patient's clinical presentation with the most appropriate next step in preventive care according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 71-year-old man who reports a history of smoking 3 to 4 cigarettes daily for about three years in his early twenties, but has abstained since. He takes amlodipine for well-controlled hypertension.
A 35-year-old woman who feels well and has no breast masses. Her mother was diagnosed with breast cancer at age 46, and her maternal aunt had ovarian cancer at age 52.
A 69-year-old man with type 2 diabetes mellitus who received a single dose of the 15-valent pneumococcal conjugate vaccine (PCV15) exactly 12 months ago.
A 22-year-old man who has sex with men, reports inconsistent condom use with multiple recent partners, and had a negative fourth-generation HIV test last week.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 71-year-old former light smoker matches with one-time abdominal aortic aneurysm screening; the 35-year-old woman with a strong family history matches with genetic counseling; the 69-year-old man who received PCV15 last year matches with PPSV23 administration; and the 22-year-old man with high-risk sexual behavior matches with HIV pre-exposure prophylaxis.
Each pairing directly applies current USPSTF and ACIP guidelines by correctly identifying the subtle triggers for screening or prophylaxis. The 71-year-old man meets the >100 lifetime cigarettes threshold for AAA screening. The 35-year-old woman's pedigree triggers BRCA risk assessment. The 69-year-old man completes his pneumococcal series with PPSV23 exactly one year after PCV15. The 22-year-old man's high-risk behavior combined with a negative HIV test warrants PrEP.

Adım Adım Çözüm

1
Evaluate the 71-year-old man's smoking history against vascular screening criteria.
He has smoked far more than 100 lifetime cigarettes, classifying him as an 'ever smoker'.
This qualifies him for the USPSTF Grade B recommendation for a one-time abdominal aortic aneurysm ultrasound screening for men aged 65-75, correcting the misconception that heavy pack-years are required for AAA screening.
2
Assess the 35-year-old woman's family oncology pedigree.
She has multiple relatives with BRCA-associated cancers (breast before age 50, ovarian cancer).
This triggers the USPSTF Grade B recommendation for administering a familial risk assessment tool and referring for genetic counseling.
3
Review the 69-year-old man's immunization timeline.
He received PCV15 exactly 12 months ago.
ACIP guidelines dictate that patients who receive PCV15 must be followed up with a dose of PPSV23 at least one year later.
4
Analyze the 22-year-old man's infectious disease risk profile.
He has high-risk sexual exposures and a recently confirmed negative HIV test.
He clearly meets criteria for initiating daily oral pre-exposure prophylaxis (PrEP).

Anahtar Kavram

Age- and risk-appropriate preventive care interventions require careful application of specific numeric thresholds (e.g., >100 lifetime cigarettes for AAA screening) and sequential timelines (e.g., PCV15 followed by PPSV23 at 1 year).
Tahmini Süre:1m 30s
Soru 771Soru →

Match each clinical scenario with the most appropriate disposition and care setting.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

75-year-old with community-acquired pneumonia, confusion, BUN 28 mg/dL, respiratory rate 32/min, and blood pressure 85/50 mmHg
82-year-old, post-operative day 5 for hip fracture repair, medically stable, requires maximum assistance for transfers, can tolerate only 45 minutes of physical therapy daily
62-year-old, post-stroke, medically stable with dense hemiparesis, capable of participating in 3 hours of intensive combined therapy daily
55-year-old with acute unprovoked deep vein thrombosis, normal vital signs, normal renal function, stable home environment

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The pneumonia patient matches to ICU admission; the hip fracture patient matches to SNF transfer; the stroke patient matches to IRF transfer; and the DVT patient matches to home discharge.
Each patient's clinical stability and functional capacity directly dictates their required care setting: CURB-65 of 4 mandates ICU; ability to tolerate 3 hours of therapy qualifies for IRF; inability to tolerate intense therapy despite needing rehabilitation directs to SNF; and stable DVT is standardly managed as an outpatient.

Adım Adım Çözüm

1
Evaluate the clinical severity of acute medical conditions to determine the appropriate acuity level.
The pneumonia patient's CURB-65 score of 4 dictates ICU-level care. The DVT patient is hemodynamically stable with no high-risk features, allowing for safe outpatient management.
Risk stratification tools like CURB-65 guide the decision between critical care, standard inpatient admission, and outpatient management.
2
Assess the functional capacity and therapy tolerance for post-acute care transitions.
The stroke patient can tolerate 3 hours of daily therapy (IRF criteria), while the hip fracture patient can only tolerate 45 minutes (SNF criteria).
Regulatory and clinical criteria strictly differentiate post-acute care settings based on the intensity of rehabilitation the patient can actively participate in.

Anahtar Kavram

Appropriate disposition requires synthesizing objective clinical severity scores (e.g., CURB-65) with functional status, primarily a patient's ability to tolerate specific therapy durations.
Soru 772Soru →

Match each end-of-life clinical scenario or surrogate decision-making context with the corresponding ethical standard or advance care planning tool.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A surrogate decision-maker refuses a feeding tube for an incapacitated patient, stating, 'He explicitly told me last year he never wanted artificial nutrition or machines keeping him alive.'
A court-appointed guardian consents to a palliative surgical procedure for an adult who has had profound intellectual disability since birth, aiming to relieve suffering.
A competent patient completes a legal document specifying their desire to refuse mechanical ventilation and artificial feeding if they ever enter a persistent vegetative state.
An active medical order set, signed by a clinician, that travels with a home hospice patient to direct emergency medical services regarding CPR and intubation in the community.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align surrogate decisions based on prior wishes to the Substituted judgment standard, decisions for those without prior capacity to the Best interest standard, future hypothetical care legal documents to a Living will, and actionable emergency medical orders to a POLST.
Each matching pair correctly identifies the distinct ethical framework or legal instrument utilized in end-of-life and palliative care decision-making. The substituted judgment standard applies when prior wishes are known; the best interest standard applies when they are not. A living will guides future care, while a POLST dictates immediate emergency response.

Adım Adım Çözüm

1
Evaluate the foundation of the surrogate's decision-making in the first two clinical scenarios.
Determine that decisions relying on known prior values utilize the substituted judgment standard, whereas decisions for individuals who never had capacity utilize the best interest standard.
Ethical frameworks dictate distinct standards for surrogates depending on the patient's historical capacity and previously expressed wishes.
2
Differentiate between the end-of-life planning documents provided in the latter two scenarios.
Identify that a legal document anticipating future states is a Living will, whereas a portable medical order for immediate execution by emergency personnel is a POLST.
Clinical applicability changes entirely based on whether a document provides general future guidance (requiring interpretation) or immediate, actionable medical orders.

Anahtar Kavram

Ethical Standards and Advance Care Planning at the End of Life
Soru 773Soru →

Match each clinical research scenario or statistical objective to the most appropriate measure of association or impact used to quantify it.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Investigators recruit hospitalized patients with severe acute pancreatitis and compare their history of thiazide diuretic use to that of patients admitted for non-pancreatic conditions.
A cardiovascular trial utilizes a Kaplan-Meier estimator to report the relative likelihood of a myocardial infarction occurring at any precise moment among patients on a novel antiplatelet drug versus standard therapy.
Researchers studying a cohort of industrial miners calculate the specific fraction of chronic beryllium disease cases that would theoretically not have occurred if the miners had never been exposed to beryllium dust.
A clinical trial demonstrates that an experimental weight-loss medication increases the absolute risk of cholelithiasis by 4%4\%. Clinicians calculate how many patients must be prescribed the drug to expect one extra case of gallstones.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios correctly match to: Case-control study with Odds Ratio (OR), Survival analysis with Hazard Ratio (HR), Proportion of disease due to exposure with Attributable Risk Percent (ARP), and Patient count for one adverse event with Number Needed to Harm (NNH).
Each statistical measure serves a highly specific epidemiological function. Case-control studies necessitate the use of an Odds Ratio because incidence cannot be directly measured. Survival analyses utilize Hazard Ratios to compare instantaneous event rates over a continuum of time. Attributable Risk Percent isolates the proportion of disease incidence directly resulting from a specific exposure. Finally, the Number Needed to Harm translates absolute risk increases into a clinically actionable patient count.

Adım Adım Çözüm

1
Analyze the pancreatitis study design.
Identified as a case-control study (comparing diseased patients to non-diseased controls based on past exposure).
Case-control studies require the Odds Ratio because true disease incidence rates are unknown.
2
Evaluate the cardiovascular trial using Kaplan-Meier estimators.
Identified as a time-to-event survival analysis.
Hazard Ratios uniquely measure the instantaneous relative risk over time, accounting for censored patient data in survival analysis.
3
Determine the metric for the fraction of disease due to beryllium.
Identified as the proportion of incidence attributable to the exposure.
Attributable Risk Percent (ARP=RR−1RRARP = \frac{RR - 1}{RR}) calculates the exact percentage of disease cases in the exposed group that are directly caused by the exposure.
4
Calculate the metric associated with a 4%4\% absolute risk increase for gallstones.
Identified as the Number Needed to Harm.
The question asks for the number of patients treated to cause one adverse event, calculated as NNH=1Absolute Risk IncreaseNNH = \frac{1}{\text{Absolute Risk Increase}}.

Anahtar Kavram

Selection of epidemiological metrics based on specific study designs and clinical objectives.
Soru 774Soru →

A hospital research ethics committee is reviewing several clinical trial protocols and post-study analyses. Match each specific trial scenario or parameter description to the statistical concept it best represents.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A trial concludes that a novel biologic significantly reduces rheumatoid arthritis flares compared to placebo, but later definitive evidence shows the drug is completely ineffective.
A small pilot study concludes a novel surgical technique does not reduce postoperative infection rates, although the technique truly is superior to the standard approach.
Before initiating a study, investigators determine there is an 80% probability they will successfully detect a true 2-day reduction in intensive care unit length of stay.
Investigators design a trial based on their hypothesis that the new cardiovascular intervention will yield a 15% absolute reduction in 30-day mortality.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios correctly match to: False positive finding = Type I error; False negative finding = Type II error; Probability of detecting a true difference = Statistical power; Anticipated magnitude of benefit = Expected effect size.
A Type I error occurs when researchers incorrectly reject a true null hypothesis (a false positive). A Type II error occurs when researchers fail to reject a false null hypothesis (a false negative). Statistical power (1−β1 - \beta) is the probability of correctly rejecting a false null hypothesis. The expected effect size is the clinically meaningful difference researchers anticipate observing between groups.

Adım Adım Çözüm

1
Analyze the first scenario regarding the biologic agent.
The trial found a significant benefit, but reality shows no effect (false positive).
Identifying that the study claimed an effect that does not exist in reality points to a Type I error.
2
Analyze the second scenario regarding the surgical technique.
The trial found no benefit, but reality shows the technique is superior (false negative).
Identifying that the study missed a true effect characterizes a Type II error.
3
Evaluate the pre-study probability calculation.
The scenario describes an 80% probability of successfully detecting a true difference.
This probability represents the study's ability to avoid a Type II error, which is statistical power.
4
Examine the hypothesized 15% reduction in mortality.
This is the clinical difference the researchers anticipate observing.
This value represents the expected effect size required to calculate the necessary sample size.

Anahtar Kavram

Understanding the definitions and clinical manifestations of Type I errors (false positives), Type II errors (false negatives), statistical power, and effect size in clinical research.
Soru 775Soru →

Match each clinical scenario to the most appropriate disposition or care setting.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

72-year-old man, 5 days post-ischemic stroke; medically stable with severe left-sided hemiparesis. He is highly motivated and able to actively participate in 3 hours of physical, occupational, and speech therapy daily.
85-year-old woman, 7 days post-hip fracture repair; medically stable but significantly deconditioned. She requires physical therapy but can only tolerate 45 to 60 minutes of activity per day due to fatigue.
65-year-old man evaluated in the emergency department for community-acquired pneumonia. He has acute confusion, BUN 35 mg/dL, respiratory rate 32/min, and blood pressure 85/50 mmHg.
58-year-old woman, 4 days into treatment for vertebral osteomyelitis. She is medically stable, fully ambulatory, independent in all activities of daily living, but requires 6 weeks of intravenous antibiotics.
78-year-old man, 10 days post-COPD exacerbation. He is medically stable but remains bedbound and requires total assistance for all activities of daily living. He has advanced dementia, no rehabilitation potential, and his family cannot provide care at home.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are based on strict clinical guidelines and Medicare criteria for facility transitions, prioritizing therapy tolerance, acuity scores (like CURB-65), and the distinction between skilled vs. custodial needs.
Matching each patient to the correct disposition setting requires applying specific criteria: IRFs strictly require 3 hours of daily therapy tolerance, SNFs are for skilled needs with lower therapy tolerance, ICUs are for critical illness (indicated by high prognostic scores like CURB-65), home infusion is optimal for stable patients needing only prolonged IV therapy, and custodial care is reserved for those lacking skilled needs but requiring ongoing ADL support.

Adım Adım Çözüm

1
Analyze the post-stroke patient's functional status and rehabilitation capacity.
The patient is stable and can tolerate 3 hours of multidisciplinary therapy daily.
Tolerating 3 hours of intensive therapy daily is the defining requirement for Inpatient Rehabilitation Facility (IRF) placement.
2
Analyze the post-operative hip fracture patient's functional status.
The patient needs rehabilitation but can only tolerate 45-60 minutes daily.
Patients requiring active rehabilitation who cannot tolerate the 3-hour IRF requirement are appropriately triaged to a Skilled Nursing Facility (SNF).
3
Calculate the CURB-65 score for the patient presenting with pneumonia.
The score is 5 (Confusion, BUN >19, RR ≥30, BP <90/60, Age ≥65).
A CURB-65 score of 3 or higher, particularly with hemodynamic compromise, indicates severe pneumonia necessitating intensive care.
4
Evaluate the osteomyelitis patient's medical needs versus functional independence.
The patient is independent in all activities of daily living but requires prolonged IV antibiotics.
Stable, independent patients requiring prolonged IV therapy can safely receive Home Infusion Services (OPAT), avoiding institutionalization.
5
Determine the bedbound patient's eligibility for skilled care versus custodial care.
The patient has no rehabilitation potential but requires total care for activities of daily living.
Without a need for skilled nursing or active physical therapy, a patient does not qualify for an SNF and requires Custodial Care (Long-Term Care).

Anahtar Kavram

Appropriate care setting disposition depends on synthesizing medical acuity (e.g., CURB-65 score), functional status, rehabilitation potential, daily therapy tolerance (3-hour rule for IRF), and the need for skilled vs. custodial care.
Soru 776Soru →

Match each patient's clinical presentation with the most appropriate post-acute care disposition setting based on standard utilization and functional criteria.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Recovering from an ischemic stroke, medically stable, exhibits severe hemiparesis but actively participates in and tolerates 3.5 hours of daily physical and occupational therapy.
Status post complicated abdominal sepsis, hemodynamically stable but requires prolonged mechanical ventilation via tracheostomy and enteral feeding via gastrostomy.
Medically stable following open reduction and internal fixation of a hip fracture, but baseline dementia and postoperative fatigue limit physical therapy participation to 45 minutes per day.
End-stage chronic obstructive pulmonary disease with resting hypoxia, recently opted to forego further intubation or hospitalizations to prioritize symptom relief at home.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The stroke patient capable of intensive therapy matches with an Inpatient Rehabilitation Facility (IRF). The ventilator-dependent patient matches with a Long-Term Acute Care Hospital (LTACH). The hip fracture patient with low endurance matches with a Skilled Nursing Facility (SNF). The advanced COPD patient prioritizing comfort matches with Home Hospice Care.
Appropriate disposition relies on matching a patient's medical complexity, rehabilitation stamina, and goals of care with the legal and functional criteria of specific facilities. LTACHs are for prolonged acute needs (vents). IRFs require 3 hours of daily therapy tolerance. SNFs are for skilled needs without the 3-hour tolerance. Hospice is for comfort-focused, end-of-life care.

Adım Adım Çözüm

1
Evaluate the patient's medical acuity and ongoing acute care needs.
The ventilator-dependent patient still requires hospital-level care (ventilator weaning), making LTACH appropriate. The others are medically stable for lower-acuity settings or home.
Differentiating between acute (LTACH) and post-acute (IRF, SNF, Home) levels of care is the first branch point in disposition planning.
2
Assess the functional capacity and therapy tolerance of the medically stable rehabilitation candidates.
The stroke patient tolerates 3.5 hours of therapy, qualifying for IRF. The hip fracture patient only tolerates 45 minutes, mandating SNF placement.
Medicare guidelines strictly dictate that IRF admission requires the ability to participate in 3 hours of intense therapy daily; those who cannot must go to a SNF.
3
Identify goals of care and disease trajectory for the remaining patient.
The end-stage COPD patient desires symptom relief over life-prolonging measures.
When curative or disease-modifying therapies are ceased in favor of comfort, and life expectancy is limited, hospice is the correct disposition.

Anahtar Kavram

Clinical criteria for post-acute care disposition (LTACH, IRF, SNF, and Hospice)
Soru 777Soru →

A biostatistics consulting group at an academic medical center is evaluating the statistical analysis plans of several proposed clinical studies. The consultants must identify the primary statistical consequence of specific trial design choices. Match each methodological decision to its most direct impact on hypothesis testing parameters.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Switching from an independent-groups design to a matched-pairs design with the same total number of participants
Conducting multiple sequential interim analyses for efficacy without adjusting the nominal significance level
Reducing the anticipated effect size (minimally clinically important difference) used in the planning phase while keeping sample size fixed
Applying a Bonferroni adjustment for analyzing multiple secondary endpoints

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

1) Matched-pairs design -> Increases power by reducing variance. 2) Multiple interim analyses -> Inflates overall Type I error rate. 3) Reducing effect size -> Increases Type II error and reduces power. 4) Bonferroni adjustment -> Maintains family-wise alpha but increases false-negatives.
Each methodological decision manipulates the delicate balance between α\alpha (false positives), β\beta (false negatives), and variance. Matched pairs isolate the intervention effect by stripping away between-subject noise (variance), boosting power. Interim analyses act as multiple 'rolls of the dice,' which compounds the risk of a false positive if unadjusted. Shrinking the target effect size without adding more participants means the study lacks the statistical 'resolution' to detect the difference, raising Type II errors. Finally, Bonferroni corrections strictly control false positives but create a highly conservative threshold that drives up false negatives.

Adım Adım Çözüm

1
Evaluate the effect of a matched-pairs design.
It controls for confounding inter-subject baseline variables.
By controlling for baseline variability, the standard error decreases, which mathematically increases the test statistic and statistical power.
2
Assess the impact of unadjusted multiple interim analyses.
It leads to repeated significance testing.
Repeatedly testing data without an alpha-spending function geometrically increases the probability of finding a false positive (inflating the Type I error rate).
3
Determine the consequence of reducing the expected effect size without altering sample size.
The trial is attempting to detect a smaller difference with the same mathematical leverage.
Detecting a smaller effect size requires a larger sample. Keeping the sample size fixed drops the study's power, increasing the risk of a Type II error (false negative).
4
Analyze the trade-off of a Bonferroni adjustment.
It sets a much stricter threshold (α/n\alpha/n) for statistical significance.
While it successfully prevents the inflation of family-wise Type I errors, the stricter threshold inherently makes it harder to detect true differences, lowering power and raising Type II error risk.

Anahtar Kavram

Hypothesis Testing and Statistical Power
Soru 778Soru →

A clinical guidelines committee is evaluating the methodology of four recent observational and experimental studies. To correctly appraise the evidence, the committee must identify the primary methodological flaw or bias affecting each study's validity. Match each study methodology description with the specific epidemiological bias it best illustrates.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A screening program detects a novel biomarker for asymptomatic pancreatic cancer 6 months earlier than standard imaging. The 3-year survival rate from diagnosis is higher in the screened cohort, but the age-specific mortality rate remains unchanged.
An observational study compares outcomes of a novel oral anticoagulant versus standard therapy. The novel agent is disproportionately prescribed to patients with severe baseline renal impairment, artificially increasing its apparent bleeding risk.
A 5-year prospective study on cognitive behavioral therapy for insomnia includes only the 45% of participants who completed all therapy sessions in its final analysis, excluding all dropouts from the results.
A retrospective case-control study investigates the link between congenital malformations and maternal herbal tea consumption. Mothers of affected infants are surveyed 5 years post-delivery about their first-trimester dietary habits.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Study 1 matches Lead-time bias; Study 2 matches Confounding by indication; Study 3 matches Attrition bias; Study 4 matches Recall bias.
Each study design flaw accurately aligns with a specific epidemiological bias. Early detection increasing apparent survival time without changing overall mortality is the hallmark of lead-time bias. Disproportionate prescription of a treatment to a sicker subgroup, which independently affects the outcome, is confounding by indication. Excluding study dropouts from the final analysis creates attrition bias (a form of selection bias). Finally, surveying patients years after a traumatic event (such as having an infant with anomalies) reliably introduces recall bias compared to a healthy control group.

Adım Adım Çözüm

1
Analyze the first study description for survival rate inflation without a true mortality benefit.
Identified as Lead-time bias.
The apparent increase in survival is purely due to earlier detection, not delayed death.
2
Analyze the second study description for baseline differences driving treatment selection.
Identified as Confounding by indication.
The indication for the drug (or provider preference for sicker patients) is independently linked to the adverse outcome (bleeding risk).
3
Analyze the third study description for the effect of excluding study dropouts.
Identified as Attrition bias.
Loss to follow-up and exclusion of non-completers skews the final population, violating intention-to-treat principles.
4
Analyze the fourth study description for potential memory discrepancies between the two groups.
Identified as Recall bias.
Having a child with anomalies prompts stronger, often disproportionate, maternal recollection of potential exposures compared to mothers of healthy children.

Anahtar Kavram

Identifying and categorizing epidemiological biases based on study design and participant follow-up flaws.
Tahmini Süre:1m 30s
Soru 779Soru →

Match each clinical study design and variable configuration with the most appropriate inferential statistical test used for data analysis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Comparing mean serum cholesterol levels (a normally distributed continuous variable) among three independent patient cohorts receiving different statin therapies.
Comparing the incidence of postoperative wound infections (a nominal categorical variable) between patients receiving prophylactic antibiotics versus placebo.
Comparing median urinary protein excretion (a highly skewed continuous variable) between patients with diabetic nephropathy and healthy controls.
Evaluating changes in mean tumor volume (a normally distributed continuous variable) within the same group of oncology patients before and after a targeted 12-week chemotherapy regimen.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align three cohorts to ANOVA, categorical infection incidence to the Chi-square test, skewed protein levels to the Mann-Whitney U test, and paired before-and-after tumor volumes to the Paired t-test.
Each study design correctly matches with the statistical test that accommodates its specific combination of variables, group numbers, and data distribution.

Adım Adım Çözüm

1
Analyze the first scenario involving three independent cohorts and a continuous, normally distributed variable.
Identified as requiring a parametric test for >2 independent groups, which is ANOVA.
ANOVA compares means across three or more independent groups when data is normally distributed.
2
Analyze the second scenario involving the incidence of infection (categorical data) in two independent groups.
Identified as requiring a test for categorical data proportions, which is the Chi-square test.
The Chi-square test evaluates associations and compares frequencies between categorical variables.
3
Analyze the third scenario involving two independent groups and a highly skewed continuous variable.
Identified as requiring a non-parametric test for two independent groups, which is the Mann-Whitney U test.
Non-parametric tests are required when continuous data heavily violates the assumption of a normal distribution.
4
Analyze the fourth scenario involving continuous, normally distributed data measured twice in the same cohort.
Identified as requiring a parametric test for paired or matched data, which is the Paired t-test.
The paired t-test compares means between two related measurements taken from the same individual.

Anahtar Kavram

Selection of the appropriate inferential statistical test is determined by the number of comparison groups, the independence of those groups (paired vs. unpaired), the data type (continuous vs. categorical), and the underlying distribution (normal vs. skewed).
Soru 780Soru →

You are reviewing a newly published randomized controlled trial evaluating a novel oral anticoagulant for stroke prevention. The pharmaceutical company has provided several documents summarizing the findings. Match each excerpted statement from the trial's methodology, results, and promotional materials to the epidemiological or statistical concept it best describes.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

The analysis included all participants in the groups to which they were originally randomized, regardless of protocol violations or treatment discontinuation.
The study was calculated to have an 80% probability of detecting a true difference in the primary outcome between the two treatment arms, should one exist.
The drug advertisement prominently claims a '33% decrease in stroke risk', derived from an event rate of 2% in the treatment group versus 3% in the placebo group.
The trial's primary efficacy measure was defined as the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke.
The study design aimed to demonstrate that the new oral anticoagulant is not unacceptably worse than the standard of care by a predefined margin.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The excerpts correctly match to Intention-to-treat analysis (Excerpt 1), Statistical power (Excerpt 2), Relative risk reduction (Excerpt 3), Composite endpoint (Excerpt 4), and Non-inferiority design (Excerpt 5).
Each excerpt accurately defines a core biostatistical concept required for evaluating clinical trials. ITT prevents attrition bias, power prevents Type II errors, RRR contextualizes the magnitude of effect relative to baseline risk, composite endpoints increase event rates for analysis, and non-inferiority designs evaluate if a drug is an acceptable alternative to standard care.

Adım Adım Çözüm

1
Analyze the first excerpt regarding patient inclusion in final analysis.
Participants are analyzed based on initial randomization regardless of compliance.
This identifies the use of Intention-to-treat (ITT) analysis, which is essential for preserving the benefits of randomization.
2
Evaluate the second excerpt describing the probability of detecting a true difference.
The 80% probability describes the study's ability to avoid a Type II error.
This directly defines statistical power.
3
Examine the third excerpt claiming a 33% decrease based on a 3% vs 2% event rate.
The 33% figure is derived mathematically by dividing the absolute risk reduction (1%) by the control event rate (3%).
This calculates the relative risk reduction (RRR), a metric frequently highlighted in promotional materials.
4
Assess the fourth excerpt listing multiple outcomes as a single measure.
The primary outcome groups death, myocardial infarction, and stroke together.
This constitutes a composite endpoint, frequently used to accrue enough events for robust statistical analysis.
5
Analyze the fifth excerpt regarding the comparison between the new drug and standard care.
The goal is to prove the new drug is not unacceptably worse by a predefined margin.
This defines the objective of a non-inferiority trial design.

Anahtar Kavram

Accurate medical literature and drug advertisement interpretation requires recognizing epidemiological trial designs, statistical metrics, and how data presentation can influence clinical perception.
ÖncekiSayfa 39 / 43Sonraki
Tüm alıştırma soruları — USMLE Step 3 | Examkin